Pharmacodynamic Differentiation of Lorazepam Sleepiness and Dizziness Using an Ordered Categorical Measure

Por Kamal, Mohamed A., Smith, David E., Cook, Jack, Feltner, Douglas, Moton, Allen, Ouellet, Daniele
Publicado em 2010

Effect of renal impairment on the pharmacokinetics of PD 0200390, a novel ligand for the voltage-gated calcium channel alpha-2-delta subunit

Por Corrigan, Brian, Feltner, Douglas E, Ouellet, Daniele, Werth, John L, Moton, Allen E, Gibson, Gordon
Publicado em 2009

Effects of lasofoxifene on the pharmacokinetics and pharmacodynamics of single-dose warfarin

Por Ouellet, Daniele, Bramson, Candace, Carvajal-Gonzalez, Santos, Roman, Doina, Randinitis, Edward, Remmers, Ann, Gardner, Mark J
Publicado em 2006

Effect of Fluoxetine on Pharmacokinetics of Ritonavir

Por Ouellet, Daniele, Hsu, Ann, Qian, Jiang, Lamm, Janet E., Cavanaugh, John H., Leonard, John M., Granneman, G. Richard
Publicado em 1998

Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers

Por Ouellet, Daniele, Hsu, Ann, Qian, Jiang, Locke, Charles S, Eason, Carolyn J, Cavanaugh, John H, Leonard, John M, Granneman, G Richard
Publicado em 1998

Concomitant oral and intravenous pharmacokinetics of trametinib, a MEK inhibitor, in subjects with solid tumours

Por Leonowens, Cathrine, Pendry, Carolyn, Bauman, John, Young, Graeme C, Ho, May, Henriquez, Frank, Fang, Lei, Morrison, Royce A, Orford, Keith, Ouellet, Daniele
Publicado no Br J Clin Pharmacol (2014)

Population Pharmacokinetics of Piperacillin Using Scavenged Samples from Preterm Infants

Por Cohen-Wolkowiez, Michael, Benjamin, Daniel K., Ross, Ashley, James, Laura P., Sullivan, Janice E., Walsh, Michele C., Zadell, Arlene, Newman, Nancy, White, Nicole R., Kashuba, Angela D. M., Ouellet, Daniele
Publicado em 2012

Population Pharmacokinetics of Metronidazole Evaluated Using Scavenged Samples from Preterm Infants

Por Cohen-Wolkowiez, Michael, Ouellet, Daniele, Smith, P. Brian, James, Laura P., Ross, Ashley, Sullivan, Janice E., Walsh, Michele C., Zadell, Arlene, Newman, Nancy, White, Nicole R., Kashuba, Angela D. M., Benjamin, Daniel K.
Publicado em 2012

Phase II Study of the MEK1/MEK2 Inhibitor Trametinib in Patients With Metastatic BRAF-Mutant Cutaneous Melanoma Previously Treated With or Without a BRAF Inhibitor

Por Kim, Kevin B., Kefford, Richard, Pavlick, Anna C., Infante, Jeffrey R., Ribas, Antoni, Sosman, Jeffrey A., Fecher, Leslie A., Millward, Michael, McArthur, Grant A., Hwu, Patrick, Gonzalez, Rene, Ott, Patrick A., Long, Georgina V., Gardner, Olivia S., Ouellet, Daniele, Xu, Yanmei, DeMarini, Douglas J., Le, Ngocdiep T., Patel, Kiran, Lewis, Karl D.
Publicado no J Clin Oncol (2013)

Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations

Por Flaherty, Keith T., Infante, Jeffery R., Daud, Adil, Gonzalez, Rene, Kefford, Richard F., Sosman, Jeffrey, Hamid, Omid, Schuchter, Lynn, Cebon, Jonathan, Ibrahim, Nageatte, Kudchadkar, Ragini, Burris, Howard A., Falchook, Gerald, Algazi, Alain, Lewis, Karl, Long, Georgina V., Puzanov, Igor, Lebowitz, Peter, Singh, Ajay, Little, Shonda, Sun, Peng, Allred, Alicia, Ouellet, Daniele, Kim, Kevin B., Patel, Kiran, Weber, Jeffrey
Publicado em 2012